NasdaqGS:DYNBiotechs
A Look At Dyne Therapeutics (DYN) Valuation After Strong Recent Share Price Momentum
Why Dyne Therapeutics is on investors’ radar today
Dyne Therapeutics (DYN) has drawn attention after recent trading, with the stock closing at US$18.84 and posting a 26.8% return over the past month. This performance has prompted closer scrutiny of its risk reward profile.
See our latest analysis for Dyne Therapeutics.
Recent trading strength, including a 9.9% 7 day share price return and a 26.8% 30 day share price return, sits alongside a 127.5% 1 year total shareholder return. This...